United States · 
Who invested in Nektar Therapeutics?
Nektar Therapeutics's investors include AstraZeneca.
United States · Venture startup
Who invested in Nektar Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Nektar Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$25Mraised across 1 round since 2013, from 1 source
- Latest round
- Venture, $25MAug 2013
- Investors
- 1
The rounds
- Aug 2013
The exit
ExitListingPriceWhen
IPONASDAQ:NKTRundisclosedMay 1994
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nektar Therapeutics
How much has Nektar Therapeutics raised?
Nektar Therapeutics has raised $25M across 1 round since 2013.
When did Nektar Therapeutics last raise?
Nektar Therapeutics's most recent round was a Venture of $25M in Aug 2013.
What was Nektar Therapeutics's biggest round?
Its most recent round, $25M in Aug 2013, is also its largest on record.
Who backed Nektar Therapeutics first?
Nektar Therapeutics's first round on record, in Aug 2013, was backed by AstraZeneca.
What stage is Nektar Therapeutics at?
Nektar Therapeutics's latest named round is a Venture, in Aug 2013.
Where is Nektar Therapeutics based?
Nektar Therapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.